Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription 08.09.2025 1 Am J Psychiatry 1 Ann Nucl Med 1 Appl Radiat Isot 1 BMC Neurol 1 Circ Cardiovasc Imaging 19 Clin Nucl Med 1 J Cereb Blood Flow Metab 1 J Neuroimaging 1 J Nucl Cardiol 8 J Nucl Med 1 JAMA 1 Neurologia (Engl Ed) 1 Neurology 3 Nucl Med Commun 2 Phys Med Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Psychiatry

1. VANO LJ, McCutcheon RA, Sedlacik J, Kaar SJ, et al
   Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study.
   Am J Psychiatry. 2025;182:830-839.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

2. ABE K, Baba S, Etani R, Fujimto T, et al
   Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan.
   Ann Nucl Med. 2025 Sep 3. doi: 10.1007/s12149-025-02102.
   PubMed         Abstract available
   
   

   
   Appl Radiat Isot

3. REYES-L S, Molina-Contreras JR, Vega-Carrillo HR
   X-ray and gamma-ray shielding capacity of recycled polyethylene terephthalate (r-PET) added with barite (BaSO(4)) and metal oxide microparticles.
   Appl Radiat Isot. 2025;226:112109.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. KOBAYASHI M
   Hemichorea as the sole clinical manifestation of spinocerebellar ataxia type 8: a case report.
   BMC Neurol. 2025;25:372.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

5. KADOYA Y, Chong AY, Small GR, Chow B, et al
   Global Microvascular Dysfunction and Incomplete Recovery in Takotsubo Syndrome: Insights From Serial PET Imaging.
   Circ Cardiovasc Imaging. 2025 Sep 3:e018266. doi: 10.1161/CIRCIMAGING.125.018266
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

6. SAMADI MH, Sahafi P, Elahifard H, Davoodi S, et al
   99m Tc-PSMA Uptake in Neurofibroma.
   Clin Nucl Med. 2025;50:e611-e613.
   PubMed         Abstract available
   
   
7. RABANI F, Saber Tanha A, Raeisi N, Jabbari Noghabi A, et al
   Lymphoscintigraphy for Peri-Anal Squamous Cell Carcinoma: A Case Report of an Atypical Location for Sentinel Lymph Node.
   Clin Nucl Med. 2025;50:e593-e595.
   PubMed         Abstract available
   
   
8. RAEISI N, Saber Tanha A, Aryana K, Nazif S, et al
   First Clinical Application of 99m Tc-FAPI-46 as an Available Radiotracer to Evaluate the Cardiac Remodeling Process : A Case Report.
   Clin Nucl Med. 2025;50:e621-e623.
   PubMed         Abstract available
   
   
9. ZHANG H, Pan Q, Liu S, Feng J, et al
   Intense Uptake of 68 Ga-exendin-4 in a Patient With WHO Grade 3 Insulinoma and Extensive Intrahepatic Metastases.
   Clin Nucl Med. 2025;50:978-980.
   PubMed         Abstract available
   
   
10. MAN X, Dong C, Song X, Dong A, et al
    Intense FDG Activity of Renal Granuloma Following Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer Mimicking Malignancy.
    Clin Nucl Med. 2025 Apr 23. doi: 10.1097/RLU.0000000000005810.
    PubMed         Abstract available
    
    
11. SPEICHER T, Burgard C, Rosar F, Bastian M, et al
    Superior Response of CAP-PRRT of G3 NET When Switching to the Somatostatin Receptor Antagonist LM3: Intraindividual Proof-of-concept.
    Clin Nucl Med. 2025;50:981-982.
    PubMed         Abstract available
    
    
12. SABER TANHA A, Raeisi N, Jafari Zarrin Ghabaei F, Aryana K, et al
    Comparable Diagnostic Performance of 99m Tc-FAPI Scintigraphy and Contrast-enhanced CT in Restaging a Rare Case of Metastatic Colon Adenocarcinoma to the Urachus.
    Clin Nucl Med. 2025;50:e626-e627.
    PubMed         Abstract available
    
    
13. NGUYEN NC, Luo J, Arefan D, Vasireddi AK, et al
    Artificial Intelligence in Sincalide-Stimulated Cholescintigraphy: A Pilot Study.
    Clin Nucl Med. 2025 May 13. doi: 10.1097/RLU.0000000000005967.
    PubMed         Abstract available
    
    
14. LIPPENS J, Cordier F, Daneels W, Genbrugge E, et al
    Case Report: Collision Tumor Involving Diffuse Large B-Cell Lymphoma (DLBCL) and Meningioma.
    Clin Nucl Med. 2025;50:e599-e601.
    PubMed         Abstract available
    
    
15. OKADA N, Otomi Y, Shinya T, Takao S, et al
    99m Tc-PYP and 99m Tc-MDP Scintigraphy in a Rare Case of Combined ApoA-I Cardiac Amyloidosis and Paget Disease of the Bone.
    Clin Nucl Med. 2025;50:946-948.
    PubMed         Abstract available
    
    
16. JAYADE SB, Alavidze M, Tonny SK, Halkar RK, et al
    Drug-induced Sarcoid-like Reaction Presenting as Fascitis.
    Clin Nucl Med. 2025;50:e589-e590.
    PubMed         Abstract available
    
    
17. WEI J, Zou K, Sun F, Feng Q, et al
    18 F-FAPI-04 PET/CT in the Evaluation of Patients With Cervical Cancers : Head-to-Head Comparison With 18 F-FDG PET/CT.
    Clin Nucl Med. 2025 Aug 21. doi: 10.1097/RLU.0000000000006103.
    PubMed         Abstract available
    
    
18. LIANG H, Dong Z, Chen F, Wei L, et al
    Lincoln Sign in a Case of Langerhans Cell Histiocytosis on Bone Scintigraphy.
    Clin Nucl Med. 2025;50:943-945.
    PubMed         Abstract available
    
    
19. BRUMENT M, Zanetta S, Drouet C
    18F-Fluorocholine PET/CT for the Staging and Follow-up of a Patient Suffering From Metastatic Parathyroid Carcinoma.
    Clin Nucl Med. 2025;50:e617-e620.
    PubMed         Abstract available
    
    
20. WANG J, Kuker RA, Yu JQM, Jain N, et al
    Characterization of Sinonasal Lesions on CT, MRI, and PET/CT.
    Clin Nucl Med. 2025 Sep 3. doi: 10.1097/RLU.0000000000006101.
    PubMed         Abstract available
    
    
21. JADHAV V, Verma P, Chandak A, Basu S, et al
    Diffuse Cutaneous Angiosarcoma Involving Scalp and Face on 18F-FDG and 68Ga-NODAGA-RGD PET/CT.
    Clin Nucl Med. 2025 Aug 25. doi: 10.1097/RLU.0000000000006113.
    PubMed         Abstract available
    
    
22. WANG R, Peng X, Wang J, Xiang J, et al
    Heterotopic Pancreas Mimicking Gastrointestinal Stromal Tumor on 68Ga-NOTA-RM26 PET/CT.
    Clin Nucl Med. 2025 Sep 1. doi: 10.1097/RLU.0000000000005982.
    PubMed         Abstract available
    
    
23. KUMAR SA, Srinivasan AA, Srinivas BH, Sethi P, et al
    Rampant Cystic Metastases From Oral Squamous Cell Carcinoma on 18F-FDG PET/CT: A Rare Clinical Presentation Showing Interplay of Inflammation and Malignancy.
    Clin Nucl Med. 2025 Aug 25. doi: 10.1097/RLU.0000000000006111.
    PubMed         Abstract available
    
    
24. ZHOU J, Zhou M, Chen W, Liu Y, et al
    68Ga-NODAGA-SNA006 PET/CT Imaging of Tumor CD8+ T-Cell Infiltration Predicts Immunotherapy Response in Lung Cancer.
    Clin Nucl Med. 2025 Sep 1. doi: 10.1097/RLU.0000000000006098.
    PubMed         Abstract available
    
    

    
    J Cereb Blood Flow Metab

25. VOLPI T, Lee JJ, Vlassenko AG, Goyal MS, et al
    The brain's "dark energy" puzzle upgraded: [(18)F]FDG uptake, delivery and phosphorylation, and their coupling with resting-state brain activity.
    J Cereb Blood Flow Metab. 2025;45:1799-1815.
    PubMed         Abstract available
    
    

    
    J Neuroimaging

26. RADMARD M, Gad M, Sheikhy A, Dagher R, et al
    Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta-Analysis of ASL-MRI and FDG-PET.
    J Neuroimaging. 2025;35:e70080.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

27. LIMA BB, Kronenberg MW, Carr CM, Duran J, et al
    How to Prepare Patients for (18)F-FDG PET Myocardial Viability Assessment.
    J Nucl Cardiol. 2025 Sep 2:102480. doi: 10.1016/j.nuclcard.2025.102480.
    PubMed        
    
    

    
    J Nucl Med

28. LANZAFAME H, Heilig CE, Wardelmann E, Desaulniers M, et al
    (90)Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors.
    J Nucl Med. 2025;66:1378-1384.
    PubMed         Abstract available
    
    
29. CHEN L, Rizzo G, Bulawa C, Van Dijk KRA, et al
    Evaluation of Mitochondrial Complex 1 Density with [(18)F]BCPP-EF in a Murine Model and Individuals with Friedreich Ataxia.
    J Nucl Med. 2025;66:1434-1439.
    PubMed         Abstract available
    
    
30. HOOIVELD-NOEKEN JS, de Ruijter LK, van de Donk PP, Smit LM, et al
    Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of Immunotherapy.
    J Nucl Med. 2025;66:1345-1351.
    PubMed         Abstract available
    
    
31. VAN BINSBERGEN WH, Zwezerijnen GJC, Windhorst AD, Schober P, et al
    SUVs Versus Dynamic Pharmacokinetic [(18)F]Fluoro-Polyethylene Glycol-Folate Uptake Parameters in Joints of Rheumatoid Arthritis Patients at Baseline and at 4 Weeks of Antitumor Necrosis Factor Therapy.
    J Nucl Med. 2025;66:1458-1463.
    PubMed         Abstract available
    
    
32. HUANG B, Dai B, Lapi SE, Liles G, et al
    High-Resolution Positronium Lifetime Tomography at Clinical Activity Levels on the PennPET Explorer.
    J Nucl Med. 2025;66:1464-1470.
    PubMed         Abstract available
    
    
33. PANDIT-TASKAR N, Basu E, Pirasteh A, Behr G, et al
    Lesion Analysis of (18)F-Metafluorobenzylguanidine PET Imaging in Neuroblastoma.
    J Nucl Med. 2025 Sep 4:jnumed.125.269833. doi: 10.2967/jnumed.125.269833.
    PubMed         Abstract available
    
    
34. GRAVEL P, Gu J, Wang C, Volpi T, et al
    Toward Imaging of the GABA Transporter Type 1 In Vivo: Quantitative Evaluation of 4 Novel PET Radiotracers in Nonhuman Primates.
    J Nucl Med. 2025 Sep 4:jnumed.125.270332. doi: 10.2967/jnumed.125.270332.
    PubMed         Abstract available
    
    
35. SMITH R, Garibotto V, Hagerstrom D, Jogi J, et al
    Evaluation of a Sensitive Visual Read Algorithm for Assessing 3R/4R Tau PET Images.
    J Nucl Med. 2025 Sep 4:jnumed.125.269685. doi: 10.2967/jnumed.125.269685.
    PubMed         Abstract available
    
    

    
    JAMA

36. ZHOU Y, He Y, Campbell BCV, Liebeskind DS, et al
    Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical Trial.
    JAMA. 2025 Aug 7. doi: 10.1001/jama.2025.12063.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

37. GIL-MONTOYA JA, Gerez-Munoz MJ, Trivino-Ibanez E, Carrera-Munoz I, et al
    Periodontal disease and brain amyloid pathology in mild cognitive impairment.
    Neurologia (Engl Ed). 2025;40:641-650.
    PubMed         Abstract available
    
    

    
    Neurology

38. WANG X, Ye T, Zhou W, Zhang J, et al
    Association of Distinct Initial beta-Amyloid Levels With Tau Pathology Expansion Beyond the Entorhinal Cortex.
    Neurology. 2025;105:e214041.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

39. BABACAN GB, Oner Tamam M, Demirel N, Mansuroglu I, et al
    Comparison of different response evaluation criteria in interim PET/computed tomography for diffuse large B-cell lymphoma: is Deltatotal metabolic tumor volume a worthwhile measure?
    Nucl Med Commun. 2025 Sep 5. doi: 10.1097/MNM.0000000000002047.
    PubMed         Abstract available
    
    
40. HASANABADI S, Aghamiri SMR, Abin AA, Cheraghi M, et al
    Automatic Lugano staging for risk stratification in lymphoma: a multicenter PET radiomics and machine learning study with survival analysis.
    Nucl Med Commun. 2025 Sep 3. doi: 10.1097/MNM.0000000000002046.
    PubMed         Abstract available
    
    
41. ADIN ME, Nguyen D, Shin C, Pucar D, et al
    COVID-19 vaccine-associated reactive axillary lymph nodes on FDG PET/CT: a systematic review and meta-analysis.
    Nucl Med Commun. 2025 Sep 3. doi: 10.1097/MNM.0000000000002041.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

42. MANCO L, Urso L, Filippi L
    One scan, many stories: deep learning for signal separation in multi-tracer PET imaging.
    Phys Med Biol. 2025 Sep 3. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
43. KUANG Z, Zhang L, Ren N, Liu Z, et al
    Effects of inter-crystal scattering events on the performance of SIAT aPET.
    Phys Med Biol. 2025;70.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.